Skip to main content
Signal8

Medicus Pharma Ltd. (MDCX) Form SCHEDULE 13D/A — Nov 17, 2026

$MDCXForm SCHEDULE 13D/AFiled Nov 17, 2026, 5:21 PM ET0000950142-26-003112Original filing

Dr. Raza Bokhari and his entity RBx Capital, LP amended their Schedule 13D on Medicus Pharma Ltd. after RBx Capital purchased 436,046 common shares at $1.72 per share in a private placement on November 13, 2026, for roughly $750,000. Following the purchase, Bokhari beneficially owns 538,233 shares (19.1%) and RBx Capital, LP holds 451,909 shares (16.2%), based on 2,788,106 shares outstanding as of November 16, 2026.

Key figures

Bokhari percent
19.1%
Shares outstanding
2788106
Rbx capital percent
16.2%
Bokhari shares owned
538233
Aggregate purchase price
$749,999.12
Private placement shares
436046
Purchase price per share
1.72
Rbx capital shares owned
451909

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Medicus Pharma Ltd. (MDCX) Form SCHEDULE 13D/A — Nov 17, 2026: AI Analysis | Signal8